Summary: The UK has experienced a big setback as major pharmaceutical companies, including AstraZeneca, Merck, MSD, and Eli Lilly, have paused or cancelled nearly...
Summary:Microsoft is investing £22 billion ($30 billion) to supercharge the UK’s AI infrastructure between 2025 and 2028. The company will build the UK’s largest...